Glen Eagle Advisors’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-75
| Closed | -$5.67K | – | 1095 |
|
|
2026
Q1 | $5.67K | Hold |
75
| – | – | ﹤0.01% | 733 |
|
|
2025
Q4 | $5.59K | Hold |
75
| – | – | ﹤0.01% | 760 |
|
|
2025
Q3 | $5.06K | Hold |
75
| – | – | ﹤0.01% | 784 |
|
|
2025
Q2 | $4.89K | Hold |
75
| – | – | ﹤0.01% | 734 |
|
|
2025
Q1 | $4.63K | Hold |
75
| – | – | ﹤0.01% | 736 |
|
|
2024
Q4 | $5.41K | Hold |
75
| – | – | ﹤0.01% | 736 |
|
|
2024
Q3 | $6.11K | Hold |
75
| – | – | ﹤0.01% | 734 |
|
|
2024
Q2 | $5.57K | Hold |
75
| – | – | ﹤0.01% | 749 |
|
|
2024
Q1 | $5.85K | Hold |
75
| – | – | ﹤0.01% | 746 |
|
|
2023
Q4 | $5.36K | Hold |
75
| – | – | ﹤0.01% | 725 |
|
|
2023
Q3 | $5.21K | Hold |
75
| – | – | ﹤0.01% | 717 |
|
|
2023
Q2 | $6.07K | Hold |
75
| – | – | ﹤0.01% | 710 |
|
|
2023
Q1 | $6.05K | Hold |
75
| – | – | ﹤0.01% | 690 |
|
|
2022
Q4 | $5.61K | Sell |
75
-200
| -73% | -$14.2K | ﹤0.01% | 697 |
|
|
2022
Q3 | $17.7K | Hold |
275
| – | – | 0.01% | 504 |
|
|
2022
Q2 | $19.1K | Hold |
275
| – | – | 0.01% | 511 |
|
|
2022
Q1 | $21.1K | Sell |
275
-50
| -15% | -$3.6K | 0.01% | 510 |
|
|
2021
Q4 | $24.9K | Hold |
325
| – | – | 0.01% | 481 |
|
|
2021
Q3 | $24K | Buy |
325
+50
| +18% | +$3.75K | 0.01% | 524 |
|
|
2021
Q2 | $18.3K | Hold |
275
| – | – | 0.01% | 574 |
|
|
2021
Q1 | $20.5K | Hold |
275
| – | – | 0.01% | 518 |
|
|
2020
Q4 | $20K | Hold |
275
| – | – | 0.01% | 502 |
|
|
2020
Q3 | $18.3K | Hold |
275
| – | – | 0.01% | 481 |
|
|
2020
Q2 | $15.7K | Sell |
275
-29
| -10% | -$1.42K | 0.01% | 482 |
|
|
2020
Q1 | $10.7K | Hold |
304
| – | – | 0.01% | 497 |
|
|
2019
Q4 | $15.9K | Buy |
304
+200
| +192% | +$9.96K | 0.01% | 500 |
|
|
2019
Q3 | $5.25K | Hold |
104
| – | – | ﹤0.01% | 632 |
|
|
2019
Q2 | $4.99K | Hold |
104
| – | – | ﹤0.01% | 624 |
|
|
2019
Q1 | $5.03K | Hold |
104
| – | – | ﹤0.01% | 582 |
|
|
2018
Q4 | $4.27K | Hold |
104
| – | – | ﹤0.01% | 575 |
|
|
2018
Q3 | $4.26K | Hold |
104
| – | – | ﹤0.01% | 580 |
|
|
2018
Q2 | $4.13K | Hold |
104
| – | – | ﹤0.01% | 565 |
|
|
2018
Q1 | $3.88K | Hold |
104
| – | – | ﹤0.01% | 557 |
|
|
2017
Q4 | $4.45K | Hold |
104
| – | – | ﹤0.01% | 523 |
|
|
2017
Q3 | $3.82K | Sell |
104
-100
| -49% | -$4.04K | ﹤0.01% | 545 |
|
|
2017
Q2 | $9.26K | Hold |
204
| – | – | 0.01% | 403 |
|
|
2017
Q1 | $8.7K | Hold |
204
| – | – | 0.01% | 393 |
|
|
2016
Q4 | $8.18K | Buy |
+204
| New | +$7.87K | 0.01% | 384 |
|
Other funds holding HOLX
Glen Eagle Advisors's HOLX Position: Q2 2026 in Review
Glen Eagle Advisors sold out of Hologic (HOLX) in Q2 2026, closing a stake of 75 shares — an estimated $5.67K sold.
Glen Eagle Advisors first reported a position in HOLX in Q4 2016 and held it in 38 quarters. The position peaked at $24.9K in Q4 2021. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.
- Glen Eagle Advisors reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
- Glen Eagle Advisors sold 75 Hologic shares in Q2 2026, an estimated $5.67K.
- Glen Eagle Advisors first reported a position in Hologic in Q4 2016 and held it in 38 quarters.
- Glen Eagle Advisors's Hologic position peaked at $24.9K in Q4 2021.
- 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.
Based on Glen Eagle Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.